Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

NICE recommends Pfizer’s Mylotarg combo in CD33-positive acute myeloid leukaemia

October 8, 2018 Sales and Marketing Mylotarg, NICE, Pfizer, acute myeloid leukaemia, leukaemia, pharma

NICE has revealed its recommendation for Pfizer’s Mylotarg (gemtuzumab ozogamicin) to be used on the NHS in the treatment of …
News
nhs_andrew_tatlow

NIHR whitepaper claims UK needs High Throughput Centres after Brexit

October 8, 2018 Sales and Marketing NHS, NIHR, UK, clinical trials, phase III

The National Institute for Health Research (NIHR) has released a new whitepaper outlining the substantial benefits NHS High Throughput Centres …
News
alzheimers_sq

Tech firm Tencent aims for 3-minute Alzheimer’s diagnosis with new partnership

October 8, 2018 Research and Development, Sales and Marketing Alzheimer's, pharma, tencent

Chinese tech firm Tencent has partnered up with London-based healthcare technology firm Medopad in a big to accelerate the diagnosis …
News

US FDA approves HPV vaccine for men and women aged 27-45

October 8, 2018 Sales and Marketing CDC, Cancer, FDA, HPV, approval, infectious diseases, vaccines

The US Food and Drug Administration have approved the use of HPV vaccine Gardasil 9 for both men and woman …
News
msd

MSD signs $117m deal with Samsung Bioepis over Janssen biosimilar

October 8, 2018 Sales and Marketing Biogen, Janssen, MSD, Samsung, Samsung Bioepis

American multinational MSD have won a $117 million contract allowing them to supply Samsung Bioepis’ Renflexis to the US Department …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

October 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Jannsen, NHS, Novartis, Novo Nordisk, dementia, top 10

As September came to a close and October began the UK was hit hard in the headlines after American firm …
News
roche_dark_0

FDA expands indication of Roche’s Hemlibra in haemophilia

October 5, 2018 Medical Communications, Sales and Marketing Hemlibra, Roche, haemophilia, pharma

The FDA has chosen to expand the label of Roche’s Hemlibra (emicizumab-kxwh), approving it for routine prophylaxis to prevent the …
News
ianread

Ian Read steps down as Pfizer CEO

October 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Ian Read, Pfizer, pharma

Ian Read is set to step down from his position as Chief Executive Officer (CEO) of American pharma firm Pfizer, …
Appointment
boardroom

The value of measuring biotech Board performance

October 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing RSA Group, biotech, board, life sciences, opinion, pharma

Nick Stephens of The RSA Group discusses the importance of stopping to quantify the effectiveness of board members within life …
Feature

New group blames PBM’s and hospitals for rising drug prices

October 4, 2018 Medical Communications, Sales and Marketing Alliance to Protect Medical Innovation, Drug pricing, PhRMA, Trunmp, aha, pharma

A new group, organised under the banner of the Alliance to Protect Medical Innovation, is blaming hospitals and PBM’s for …
News

Lilly’s Verzenio gets first-line EU approval for HER2- advanced breast cancer

October 3, 2018 Research and Development, Sales and Marketing Cancer, Eli Lilly, Verzenio, breast cancer, pharma

The European Medicines Agency has confirmed its approval of Eli Lilly’s CDK4/6 inhibitor Verzenio (ademaciclib), it has emerged. The therapy …
News
ianread

Pfizer CEO Ian Read set to step down from head position

October 1, 2018 Manufacturing and Production, Sales and Marketing Albert Bourla, CEO, COO, Ian Read, Pfizer, Stock Markets

Ian Read is set to step down from his position as Chief Executive Officer (CEO) of American pharma firm Pfizer, …
News
shutterstock_235920349

Are biosimilars key to solving NHS access concerns?

October 1, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Pfizer, UK, biosimilars, celltrion, pharma

In light of continued austerity gripping the NHS, it was uplifting to hear in July that the health service had …
Feature

European countries unprepared for Alzheimer’s innovations, study shows

October 1, 2018 Sales and Marketing Alzheimer's dementia, Alzheimer’s & dementia, EU, Euroepan Union, RAND corporation, research

European healthcare systems are not prepared for new developments in preventative therapies for Alzheimer’s disease, according to research conducted by …
News
nhs_sign

NHS England to fund availability of Janssen’s single tablet HIV combo Symtuza

October 1, 2018 Sales and Marketing HIV, Janssen, NHS, Symtuza, pharma

Great news for HIV patients in the UK as Janssen reveals that NHS England will provide critical funding for its …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025